Acoramidis reduces cardiovascular mortality (CVM): results at month 42 from the ATTRibute-CM open-label extension (OLE) study
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Stanford University School of Medicine, Palo Alto (United States of America)
5 More presentations in this session
Doctor J. Costantino (Rome, IT)
Professor S. Spethmann (Berlin, DE)
Doctor M. Autherith (Vienna, AT)
Mr S. Muller (Utrecht, NL)
Doctor M. Oerlemans (Utrecht, NL)
Doctor C. Kronberger (Vienna, AT)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
